ArticleNature communications2026
Inference of spatial chromatin accessibility via integration of spatial transcriptomics and single-cell multi-omics data.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Inference of spatial chromatin accessibility via integration of spatial transcriptomics and single-cell multi-omics data.Nature communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Integrating spatial transcriptomics, which maps gene expression location within tissues, with single-cell multi-omics data, profiling gene expression and chromatin accessibility (or other epigenomic data) for the same cell, offers powerful insights into gene regulation. However, commercially available kits for simultaneous spatial multi-omics profiling are currently unavailable, hindering widespread data generation. Here, we present ISON (Integrated Spatial Omics Network), a unified computational method for integrative spatial multi-omics analysis from single cell multiome data and spatial transcriptomics data. ISON accurately predicts chromatin accessibility profiles for spatial spots and reconstructs spatially resolved gene regulatory networks, demonstrating scalability in both time and memory. Importantly, ISON's chromatin accessibility prediction captures patterns consistent with cis- and trans- regulatory information and enables estimation of transcription factor (TF) activity at the spot level, distinguishing between TFs even within the same family, which is unique and is not present in approaches relying solely on chromatin accessibility data. The application of ISON to Alzheimer's disease data reveals disease- and age-specific spatially variable gene regulatory modules, highlighting its potential to uncover spatially organized mechanisms driving complex biological processes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.